Discover how the tumor microenvironment actively secretes molecules that shield cancer cells from PI3Kδ inhibitors in marginal zone lymphoma, and the breakthrough combination therapies overcoming this resistance.
Remembering Thomas J. Byers, the molecular biologist who pioneered genetic classification of Acanthamoeba and transformed our understanding of parasite infections.
Exploring how non-coding RNAs, once considered genomic 'junk', are revolutionizing our understanding of disease and medicine.
Discover how TIGD1, a transposable element derived from junk DNA, promotes oral squamous cell carcinoma progression by evading immune responses.
Discover how targeting SIRT1 protein can stop melanoma progression through proteomics research and innovative therapies.
Discover the hidden world of cap-independent translation in human and viral genomes, revealing alternative protein production mechanisms with medical implications.
Cutting-edge research from the 97th Annual Meeting of the Potato Association of America on potato preservation, disease resistance, and storage innovations.
Exploring how microarray technology enables breakthrough detection of microRNAs with attomolar sensitivity, revolutionizing disease diagnosis.
Exploring how genomics-derived pharmaceuticals are revolutionizing medicine through DNA decoding, CRISPR technology, and AI-driven drug discovery.
Exploring how epigenetics reveals a dynamic layer of biological control where experiences and environment sculpt gene expression without altering the genetic code itself.